Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc (NYSE: HLN) covers the month of May 2025. The report discloses the company's total voting rights and capital structure as of April 30, 2025. Haleon operates as a global leader in consumer health with a portfolio spanning Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements (VMS).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on capital structure and voting rights rather than financial performance.
Material Changes
The filing does not disclose material changes in financial performance compared to prior periods. It provides a static snapshot of share capital as of April 30, 2025.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It serves strictly as a notification of share counts for regulatory compliance under the FCA's Disclosure Guidance and Transparency Rules.
Capital Structure Details
| Metric | Value |
|---|---|
| Total Ordinary Shares Issued | 9,020,990,697 |
| Treasury Shares | 4,080,205 |
| Ordinary Shares with Voting Rights | 9,016,910,492 |
| Share Par Value | £0.01 each |
Investor Verification Checklist
- Verify the denominator for notification obligations is 9,016,910,492 voting shares.
- Confirm the treasury share count of 4,080,205 held as of April 30, 2025.
- Note that this filing does not contain financial results; refer to Form 20-F or quarterly earnings releases for performance data.
- Contact the Company Secretary at company.secretary@haleon.com for notifiable interest submissions.